Some circRNAs also influence therapeutic outcomes: circRNA_0025202 enhances tamoxifen sensitivity in ER-positive malignant breast tumors [177], while hsa_circ_0000199, which is elevated in TNBC, modulates response to chemotherapy and improves treatment efficacy when suppressed [178]. Here, ESR1 is linked to breast cancer.